Results 261 to 270 of about 135,997 (338)
Some of the next articles are maybe not open access.
Caspian Journal of Internal Medicine, 2017
Background: Migraine is a common type of headache. Sometimes adequate pain relief is not achieved by conventional treatments. Acupuncture and botulinum toxin-A injection are known as non-pharmacological interventions for this purpose.
Bahram Naderinabi +7 more
semanticscholar +1 more source
Background: Migraine is a common type of headache. Sometimes adequate pain relief is not achieved by conventional treatments. Acupuncture and botulinum toxin-A injection are known as non-pharmacological interventions for this purpose.
Bahram Naderinabi +7 more
semanticscholar +1 more source
Botulinum B Toxin as an Alternative to Botulinum A Toxin
Ophthalmic Plastic & Reconstructive Surgery, 1993Histochemical effects of botulinum B toxin were studied on fibers from longissimus dorsi muscle in Albino rabbits and compared to effects produced by botulinum A toxin. Acetylcholinesterase staining, muscle fiber size analysis, and ATPase staining indicated botulinum B toxin produced a denervation gradient and field similar to that produced by ...
G E, Borodic +4 more
openaire +2 more sources
Critical Care Clinics, 2005
Botulinum toxin is regarded as the most lethal substance known. It is estimated that the human LD50 for inhalation botulism is 1 to 3 nanograms of toxin/kilogram body mass. Although only three cases of inhalational botulism have been described, an understanding of the pathophysiology of food-borne outbreaks, wound botulism, and infant botulism, and ...
openaire +2 more sources
Botulinum toxin is regarded as the most lethal substance known. It is estimated that the human LD50 for inhalation botulism is 1 to 3 nanograms of toxin/kilogram body mass. Although only three cases of inhalational botulism have been described, an understanding of the pathophysiology of food-borne outbreaks, wound botulism, and infant botulism, and ...
openaire +2 more sources
Pharmacology of botulinum toxin
Journal of the American Academy of Dermatology, 2000Botulinum toxin has a well-defined role among dermatologists for the treatment of facial wrinkling, brow position, and palmar and axillary hyperhidrosis.The purpose of this study is to educate dermatologists on the pharmacology of botulinum toxin.A retrospective review of the literature on botulinum toxin from 1962 to the present was conducted.
W, Huang, J A, Foster, A S, Rogachefsky
openaire +2 more sources
Dermatologic Surgery, 2000
Botulinum toxin has been used successfully for the treatment of hyperfunctional facial lines.To determine the alteration in brow position after botulinum toxin treatment of the brow depressor muscles.Eleven women, 30-60 years old, were treated. Prior to treatment, brow position was measured relative to the pupil.
W, Huang, A S, Rogachefsky, J A, Foster
openaire +2 more sources
Botulinum toxin has been used successfully for the treatment of hyperfunctional facial lines.To determine the alteration in brow position after botulinum toxin treatment of the brow depressor muscles.Eleven women, 30-60 years old, were treated. Prior to treatment, brow position was measured relative to the pupil.
W, Huang, A S, Rogachefsky, J A, Foster
openaire +2 more sources
Innovation in Botulinum Toxins
Dermatologic ClinicsThis study aims to analyze and discuss recent trials of high-dose and liquid toxins for treating moderate to severe glabellar lines. A comprehensive review of clinical studies and patient outcomes data was conducted to assess the effectiveness and safety profiles of high-dose and liquid toxins.
Reema, Rashied, Michael H, Gold
openaire +2 more sources
American Journal of Physical Medicine & Rehabilitation, 2004
In the United States, the popularity of botulinum toxins as agents to treat muscle hypertonia has grown significantly over the last decade, despite lack of approval from the Food and Drug Administration for the indication of spasticity. Botox (botulinum toxin type A) and Myobloc (botulinum toxin type B) are Food and Drug Administration-approved for ...
openaire +2 more sources
In the United States, the popularity of botulinum toxins as agents to treat muscle hypertonia has grown significantly over the last decade, despite lack of approval from the Food and Drug Administration for the indication of spasticity. Botox (botulinum toxin type A) and Myobloc (botulinum toxin type B) are Food and Drug Administration-approved for ...
openaire +2 more sources
Botulinum toxin to avoid component separation in midline large hernias.
Surgery, 2020BACKGROUND The goal of our study was to compare results in patients with large midline incisional hernia using modified anterior component separation versus preoperative botulinum toxin and following Rives repair, with a focus on surgical site ...
J. Bueno-Lledó +4 more
semanticscholar +1 more source
Efficacy of botulinum toxin for treating a gummy smile.
American Journal of Orthodontics and Dentofacial Orthopedics, 2020INTRODUCTION This study was conducted to investigate the efficacy of botulinum toxin applied to the different muscles of patients who have excessive gingival display and to evaluate the return to baseline gingival exposure value.
A. Cengiz, M. Goymen, C. Akçalı
semanticscholar +1 more source

